Major players in the breast imaging devices market are Siemens Healthcare, GE Healthcare, Dilon Technologies Inc, Hologic Inc, Gamma Medica Inc, Fujifilm Holdings Corporation, SonoCine Inc, Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology Inc.
New York, May 13, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Breast Imaging Devices Global Market Report 2022" - https://www.reportlinker.com/p06277240/?utm_source=GNW
The global breast imaging devices market is expected to grow from $4.06 billion in 2021 to $4.31 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The market is expected to grow to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%.
The breast imaging devices market consists of sales of breast imaging devices and related services by entities (organizations, sole traders, and partnerships) that manufacture breast imaging devices. Breast imaging devices are medical devices used in the diagnosis of medical conditions related to the breast.
The main product types in breast imaging devices are tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others.Tomosynthesis is an imaging method that is utilized to screen early signs of breast cancer in people with no symptoms.
This kind of imaging can also be utilized as a diagnostic tool for a person who is having breast cancer symptoms.The technologies involved in breast imaging devices are ionizing and non-ionizing.
These are used in hospitals and clinics, breast care centers, and diagnostic imaging centers.
North America was the largest region in the breast imaging devices market in 2021.Asia Pacific was the second largest market in breast imaging devices market.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The rising prevalence of breast cancer is anticipated to contribute to the breast imaging devices market’s growth.A growing number of hormone replacement therapy (HRT), hormonal imbalances, menopause, and various reproductive disorders have significantly increased the risks of breast cancer.
According to the World Health Organization (WHO), breast cancer is the most common cancer in women, impacting 2.1 million women annually. Breast cancer causes the highest number of cancer-related deaths among women. For instance, in 2020, according to the American Institute of cancer research, there were an estimated 18.1 million cancer cases around the world. It was estimated that 9.3 million cases were in men and 8.8 million in women. Among them, lung and breast cancers are the most common cancers in the world, and about 12.5% and 12.2% of the new cases are diagnosed in 2020.
The high cost associated with breast imaging devices is expected to limit the growth of the market shortly.The cost of digital mammography systems varies for different models and companies.
For instance, the cost of the 2D model’s mammography systems ranges between $65,000 to $95,000 for GE Healthcare and Hologic, Inc products.Whereas 3D models of the same company range between $90,000 to $200,000.
In addition to this, the premium 3D models of GE Healthcare and Hologic Inc. are priced between $1,40,000 to $2,75,000. Therefore, the high cost of breast imaging systems is a major concern for end-users, which is predicted to hinder the growth of the breast imaging devices market over the forecast period.
Major players operating in the breast imaging devices market are undertaking various strategic initiatives such as the launch of technologically advanced or innovative products and product portfolio expansion, which is likely to be a leading trend in the breast imaging market.Various companies are introducing new advanced devices in the market to attract a large customer base and maintain their position in the competitive business environment.
For instance, in March 2021, Siemens Healthineers, a company operating in breast imaging devices based in Germany launched a new software solution Mammovista B.smart that works on AI technology and boosts the breast image reading process, tracks, and analyses the workflow. It has features such as it reduces the loading time and helping the radiologist in reading the number of patient databases.
In June 2019, Hologic, Inc., a USA-based innovative medical technology company focused on improving women’s health and well-being through early treatment and diagnosis, announced the acquisition of SuperSonic Imagine for an amount of $85 million. With the acquisition of SuperSonic Imagine, Hologic, Inc. aims to gain entry into cart-based breast ultrasound technology used to screen women with dense breast tissue. SuperSonic Imagine is a France-based company specialized in ultrasound medical imaging including breast imaging devices.
The countries covered in the breast imaging devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Read the full report: https://www.reportlinker.com/p06277240/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001